Some countries have already restricted the shot's use, but European regulators say it's worth using the vaccine mid-pandemic.
A combination of vaccines could help distribution problems—and potentially increase protection against variants.
US experts said the recently published trial results included outdated data that provided an "incomplete view of the efficacy."
Here’s everything you need to know this week.
As the new coronavirus variant spreads, it might create spikes in cases around the globe.
The drug company says it could produce three million doses of the vaccine in 2021 if it is approved.
The company is reviewing an adverse reaction that occurred in a patient in the U.K.
Like science, tech, and DIY projects?
Sign up to receive Popular Science's emails and get the highlights.